The final purpose would be to use leptin administration (gradually decreasing) during the period of time required by the body in order to adapt to the changes in leptin levels from obesity to post-bariatric surgeries or liposuction, via avoiding the detection by the brain of the sudden decrease in leptin levels. This evidence concerns the gene LEP and obesity disorder.